The initial immune response to hiv and immune system activation determine the outcome of hiv disease

Journal of Acquired Immune Deficiency Syndromes

Volumn 4, Issue 7, 1991, Pages 704-712

  Sheppard, Haynes W ^a   Ascher, Michael S ^a   McRae, Brian ^a   Anderson, Robert E ^a   Lang, William ^a   Allain, Jean Pierre ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

Immune activation; Immune response; Prognostic markers

Indexed keywords

MARKER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROGNOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; BIOLOGICAL MARKERS; BIOPTERIN; CD4-POSITIVE T-LYMPHOCYTES; FOLLOW-UP STUDIES; GENE PRODUCTS, GAG; HIV ANTIBODIES; HIV ANTIGENS; HIV CORE PROTEIN P24; HUMAN; LEUKOCYTE COUNT; MALE; MIDDLE AGE; NEOPTERIN; SAN FRANCISCO; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VIRAL CORE PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0026008595     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: None     Document Type: Article

References (0)